Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pharmacol Ther ; 235: 108159, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-35183589

RESUMEN

Bamboo is a medicinal plant, and has long been used as a traditional/folk medicine and a food preservative in Japan. Bamboo leaf contains many active ingredients with medicinal benefits. In particular, recent studies demonstrated that bamboo leaf extract and its constituents have great potential to prevent infectious, inflammatory, cardiovascular, metabolic, and neurological/neuropsychiatric diseases. In this review, we summarize the prophylactic and possible therapeutic effects of bamboo leaf extract and its constituent compounds against these disorders. The effects of the extract are explainable in part by the effects of some constituent compounds: p-coumaric acid, myricetin, orientin, stachyose, and vitexin. Moreover, coenzyme Q10, an anti-oxidative constituent, alleviates oxidative stress which underlies the common pathogenic mechanisms of the development of diabetic complications, atherosclerosis and periodontal disease. Some flavonoids contained in bamboo leaf, such as orientin and vitexin, have been reported to regulate gut microbiota responsible for maintaining whole-body functions, suggesting a possible interaction between bamboo leaf extract and probiotics. Thus, bamboo leaf is a valuable natural resource for the development of multiple pharmacotherapies.


Asunto(s)
Aterosclerosis , Extractos Vegetales , Aterosclerosis/tratamiento farmacológico , Aterosclerosis/prevención & control , Humanos , Estrés Oxidativo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
2.
J Asian Nat Prod Res ; 10(1-2): 159-67, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18253884

RESUMEN

In the present study, we investigated the potential anti-angiogenic mechanism and anti-tumour activity of beta-eudesmol using in vitro and in vivo experimental models. Proliferation of human umbilical vein endothelial cells (HUVEC) stimulated with vascular endothelial growth factor (VEGF, 30 ng/ml) and basic fibroblast growth factor (bFGF, 30 ng/ml) was significantly inhibited by beta-eudesmol (50-100 microM). Beta-eudesmol (100 microM) also blocked the phosphorylation of cAMP response element binding protein (CREB) induced by VEGF (30 ng/ml) in HUVEC. Beta-eudesmol (10-100 microM) inhibited proliferation of HeLa, SGC-7901, and BEL-7402 tumour cells in a time- and dose-dependent manner. Moreover, beta-eudesmol treatment (2.5-5 mg/kg) significantly inhibited growth of H(22) and S(180) mouse tumour in vivo. These results indicated that beta-eudesmol inhibited angiogenesis by suppressing CREB activation in growth factor signalling pathway. This is the first study to demonstrate that beta-eudesmol is an inhibitor of tumour growth.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Proliferación Celular/efectos de los fármacos , Neoplasias/irrigación sanguínea , Neoplasias/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Sesquiterpenos de Eudesmano/farmacología , Animales , Antineoplásicos Fitogénicos/uso terapéutico , Línea Celular Tumoral , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Células Endoteliales/efectos de los fármacos , Factor 2 de Crecimiento de Fibroblastos/farmacología , Humanos , Masculino , Ratones , Estructura Molecular , Neoplasias/patología , Fosforilación , Fitoterapia , Sesquiterpenos de Eudesmano/uso terapéutico , Factores de Tiempo , Factor A de Crecimiento Endotelial Vascular/farmacología
3.
Pharmacol Ther ; 117(2): 280-95, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18048101

RESUMEN

Ischemia and reperfusion (I/R) exerts multiple insults in microcirculation, frequently accompanied by endothelial cell injury, enhanced adhesion of leukocytes, macromolecular efflux, production of oxygen free radicals, and mast cell degranulation. Since the microcirculatory disturbance results in injury of organ involved, protection of organ after I/R is of great importance in clinic. Salvia miltiorrhiza root has long been used in Asian countries for clinical treatment of various microcirculatory disturbance-related diseases. This herbal drug contains many active water-soluble compounds, including protocatechuic aldehyde (PAl), 3,4-dihydroxyphenyl lactic acid (DLA) and salvianolic acid B (SalB). These compounds, as well as water-soluble fraction of S. miltiorrhiza root extract (SMRE), have an ability to scavenge peroxides and are able to inhibit the expression of adhesion molecules in vascular endothelium and leukocytes. Moreover, lipophilic compounds of SMRE also prevent the development of vascular damage; NADPH oxidase and platelet aggregation are inhibited by tanshinone IIA and tanshinone IIB, respectively, and the mast cell degranulation is blunted by cryptotanshinone and 15,16-dihydrotanshinone I. Thus, the water-soluble and lipophilic compounds of SMRE appear to improve the I/R-induced vascular damage multifactorially and synergically. This review will summarize the ameliorating effect of compounds derived from SMRE on microcirculatory disturbance and target organ injury after I/R and will provide a new perspective on remedy with multiple drugs.


Asunto(s)
Encéfalo/irrigación sanguínea , Fármacos Cardiovasculares/farmacología , Medicamentos Herbarios Chinos/farmacología , Riñón/irrigación sanguínea , Hígado/irrigación sanguínea , Pulmón/irrigación sanguínea , Extractos Vegetales/farmacología , Daño por Reperfusión/tratamiento farmacológico , Salvia miltiorrhiza , Animales , Plaquetas/efectos de los fármacos , Fármacos Cardiovasculares/química , Fármacos Cardiovasculares/aislamiento & purificación , Fármacos Cardiovasculares/uso terapéutico , Degranulación de la Célula/efectos de los fármacos , Circulación Cerebrovascular/efectos de los fármacos , Circulación Coronaria/efectos de los fármacos , Citocinas/metabolismo , Medicamentos Herbarios Chinos/uso terapéutico , Células Endoteliales/efectos de los fármacos , Humanos , Leucocitos/efectos de los fármacos , Circulación Hepática/efectos de los fármacos , Mastocitos/efectos de los fármacos , Microcirculación/efectos de los fármacos , Estructura Molecular , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Daño por Reperfusión Miocárdica/fisiopatología , Extractos Vegetales/uso terapéutico , Raíces de Plantas , Circulación Renal/efectos de los fármacos , Daño por Reperfusión/metabolismo , Daño por Reperfusión/fisiopatología , Salvia miltiorrhiza/química
4.
Chem Pharm Bull (Tokyo) ; 52(10): 1200-3, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15467235

RESUMEN

Two new polypodane-type triterpenes, myrrhanol A and myrrhanone A, were isolated from the 50% aqueous methanolic extract of guggul-gum resin [the resin of Balsamodendron (=Commiphora) mukul HOOK]. The structures of the new constituents, including their absolute configurations, were determined on the basis of chemical and physicochemical evidence.


Asunto(s)
Commiphora , Resinas de Plantas/química , Triterpenos/química , Espectroscopía de Resonancia Magnética , Conformación Molecular , Extractos Vegetales/química , Estereoisomerismo , Triterpenos/aislamiento & purificación
5.
BMC Pharmacol ; 4: 18, 2004 Aug 26.
Artículo en Inglés | MEDLINE | ID: mdl-15331020

RESUMEN

BACKGROUND: Green tea is widely consumed in Asian countries and is becoming increasingly popular in Western countries. Epidemiologically, it has been suggested that green tea consumption prevents type 2 diabetes. The present study was aimed at providing evidence of improvement in glucose metabolism in diabetic mice and healthy humans upon green tea consumption. RESULTS: Green tea promoted glucose metabolism in healthy human volunteers at 1.5 g/body in oral glucose tolerance tests. Green tea also lowered blood glucose levels in diabetic db+/db+ mice and streptozotocin-diabetic mice 2-6 h after administration at 300 mg/kg without affecting serum insulin level, whereas no effect was observed in control mice (+m/+m and normal ddY mice). The serum protein profiles of db+/db+ and +m/+m mice were analyzed for the first time by SELDI (surface-enhanced laser desorption/ionization)-TOF (time-of-flight)-MS (mass spectrometry), and then compared to investigate any effects of oral green tea administration on serum proteins. The protein profiles in db+/db+ mice showed that the spectral peak intensities at the mass/charge ratios (m/z) of 4119, 4203, 4206, 4211, 4579, 9311 and 18691 were >3 times lower, and those of 13075, 17406, 17407, 17418, 17622, 18431 and 26100 were >3 times higher than respective peak intensities in +m/+m mice. When green tea was administered to db+/db+ mice, the peak intensities were markedly decreased at m/z 11651 and 11863, and slightly decreased at m/z 4212. The peak intensities at 7495, 7595, 7808, 14983, 15614, 31204 were markedly increased after the administration. CONCLUSION: The present study provides evidence that green tea has an antidiabetic effect. Although we could not find simple reversed effect of green tea on the diabetes-induced modifications of the levels of several serum proteins, we found that the 4211 (4212) Da protein level that was decreased in the diabetic state was further decreased after green tea administration. This is the first report demonstrating that a certain serum protein may be involved in the antihyperglycemic effect of green tea. The contribution of this protein should be further studied.


Asunto(s)
Glucemia/efectos de los fármacos , Camellia sinensis/química , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Tipo 2/sangre , Fitoterapia/métodos , Preparaciones de Plantas/farmacología , Proteoma/metabolismo , Animales , Bebidas/clasificación , Proteínas Sanguíneas , Modelos Animales de Enfermedad , Prueba de Tolerancia a la Glucosa/métodos , Hipoglucemiantes/metabolismo , Insulina/sangre , Masculino , Ratones , Ratones Endogámicos C57BL
6.
Bioorg Med Chem ; 12(11): 3037-46, 2004 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-15142562

RESUMEN

The methanolic extract from guggul-gum resin, the resin of Balsamodendron mukul, was found to inhibit nitric oxide production in lipopolysaccharide-activated mouse peritoneal macrophages (IC(50) = 13 microg/mL). From the methanolic extract, three new polypodane-type triterpenes, myrrhanol B and myrrhanones B and A acetate, and a new octanordammarane-type triterpene, epimansumbinol, were isolated together with 17 known compounds including progesterone and the related steroids. The absolute stereostructures of new triterpenes were elucidated on the basis of chemical and physicochemical evidence. The several constituents showed inhibitory effects on nitric oxide production and induction of inducible nitric oxide synthase.


Asunto(s)
Óxido Nítrico/biosíntesis , Extractos Vegetales/química , Plantas Medicinales/química , Triterpenos/química , Triterpenos/farmacología , Animales , Commiphora , Macrófagos/enzimología , Metanol/química , Ratones , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II , Extractos Vegetales/farmacología , Gomas de Plantas , Estereoisomerismo , Triterpenos/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA